lymphoma
Calithera Biosciences Acquires Takeda Cancer Drugs in $45M Deal
The company will begin Phase II trials of sapanisertib in NSCLC and mivavotinib in diffuse large B-cell lymphoma in 2022.
BostonGene Helping MassGeneral Improve Understanding of Follicular Lymphoma Progression, Treatment
The company will analyze tumor genetics and microenvironments to advance research into why some follicular lymphomas become aggressive and treatment response.
Gilead Files for FDA Approval of Second-Line Yescarta for Large B-Cell Lymphoma
Based on data from the ZUMA-7 trial, Gilead subsidiary Kite has filed an sBLA with the agency to expand the label for its CAR T-cell therapy.
Chinese Regulators Approve JW Therapeutics' CAR T-Cell Therapy for Large B-Cell Lymphoma
Shanghai-based JW's relma-cel is the second CAR T-cell therapy to be approved by China's National Medical Products Administration.
Viracta Therapeutics Buys Back Rights to Nanatinostat, Valcyte Combo in China
The firm has reacquired rights from Shenzhen Salubris Pharmaceuticals to develop and commercialize the combination for EBV-positive lymphoma patients in China.
Aug 6, 2021